Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Change in Cash (2018 - 2025)

AdaptHealth has reported Change in Cash over the past 8 years, most recently at $25.8 million for Q4 2025.

  • Quarterly results put Change in Cash at $25.8 million for Q4 2025, up 169.46% from a year ago — trailing twelve months through Dec 2025 was -$3.6 million (down 111.07% YoY), and the annual figure for FY2025 was -$3.6 million, down 111.07%.
  • Change in Cash for Q4 2025 was $25.8 million at AdaptHealth, up from $11.7 million in the prior quarter.
  • Over the last five years, Change in Cash for AHCO hit a ceiling of $158.5 million in Q3 2021 and a floor of -$187.0 million in Q4 2021.
  • Median Change in Cash over the past 5 years was $10.3 million (2023), compared with a mean of $308700.0.
  • Peak annual rise in Change in Cash hit 282.55% in 2023, while the deepest fall reached 8991.28% in 2023.
  • AdaptHealth's Change in Cash stood at -$187.0 million in 2021, then skyrocketed by 65.53% to -$64.5 million in 2022, then soared by 132.56% to $21.0 million in 2023, then plummeted by 54.42% to $9.6 million in 2024, then soared by 169.46% to $25.8 million in 2025.
  • The last three reported values for Change in Cash were $25.8 million (Q4 2025), $11.7 million (Q3 2025), and $15.0 million (Q2 2025) per Business Quant data.